Published on: July 15, 2016
by Alzheimers New Today:
A simple number naming test can identify those with cognitive impairment among elderly individuals, clearly differentiating patients with dementia and people with mild cognitive impairment from cognitively healthy people.
The study, “Screening Utility of the King-Devick Test in Mild Cognitive Impairment and Alzheimer Disease Dementia,” published in the journal Alzheimer’s Disease and Associated Disorders, provides clinicians with a tool for selection of individuals who might benefit from more extensive testing.
Diagnosing Alzheimer’s disease is far from a straightforward process, and with the current knowledge available, a definitive diagnosis can only be set when examining the brain after a patient dies.
Nevertheless, recent research advances have produced tests allowing more accurate diagnoses, but such tests are often both invasive — measuring levels of molecules in liquid collected by a spinal tap — and expensive. Therefore, a better way to select patients who should undergo these tests would benefit both patients and doctors.
Researchers from the Boston University Alzheimer’s Disease Center, Harvard Medical School, and the New York University School of Medicine worked together to assess whether a test commonly used to detect concussion might also be used to differentiate cognitive decline.
The test, called King-Devick (K-D), usually takes one to two minutes to complete, and has also been used to quantify the level of impairment in other neurological diseases, such as Parkinson’s disease and multiple sclerosis.
In addition to the speed of completion, the test has the beneficial feature that it can be administered by non-trained office staff, and exists as both a paper version and as an electronic form adapted to tablet computers.
Researchers put 206 individuals through the test, of which 135 were cognitively healthy, 39 had mild cognitive impairment, and 32 suffered Alzheimer’s dementia. The study shows that the number test placed participants in the correct category 90 percent of the time, and was as accurate in detecting milder impairment as it was in identifying Alzheimer’s patients. Results of the number test also correlated well with more comprehensive neuropsychological tests.
Senior study author Robert Stern, director of the Clinical Core of the Alzheimer’s Disease Center and a professor of neurology, suggested that the number test could become a good screening tool in a primary care setting, allowing physicians to detect early changes needing a more thorough dementia investigation.
“Alarmingly, Alzheimer’s disease is underdiagnosed in nearly half of the American population, and the brain changes of Alzheimer’s disease may begin up to 20 years before clinical symptoms. There is a need, therefore, for sensitive and readily available screening tools that can detect Alzheimer’s disease in its early stages, particularly as potential disease-modifying therapies become available,” Stern said in a news release.
Thanks to the ongoing support of our partner Brain Canada, and The Citrine Foundation of Canada, Women’s Brain Health Initiative’s newest edition of MIND OVER MATTER has just been published. Loaded with interesting science-based articles, MIND OVER...
On December 2nd, in celebration of Women’s Brain Health Day, join thousands of others and take part in the Stand Ahead® Memory Challenge to stand up against research bias and stand ahead for women’s brain...
YOU’RE INVITED! On December 2nd, the second annual Women’s Brain Health Day, take the memory challenge and help us combat brain-aging diseases that disproportionately affect women. Join CTV’s Pattie Lovett-Reid and Anne-Marie Mediwake, along...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.